Firy Inc. vs 22nd Century Group Inc — how do they compare? Firy Inc. trades at $8.44 (market cap $125.48M), while 22nd Century Group Inc trades at $4.27 (market cap $1.52M). The key difference: Firy Inc. is far larger — about 82.6× 22nd Century Group Inc's market cap. Which is the better fit depends on your goals.
| FIRY | XXII | |
|---|---|---|
Market Cap | $125.48M | $1.52M |
Sector | Consumer Cyclical | Technology |
52-Week High | $12.45 | $1.47K |
52-Week Low | $2.28 | $3.90 |
Enterprise Value | $69.16M | -$6.71M |
Signals from Pluang's Aura AI — not financial advice
FIRY (formerly Skillz Inc.) trades at $8.04, down 4.74% today, amid mixed technical signals with a bullish overall trend but neutral oscillators. The company recently rebranded and reported Q1 2026 results showing revenue growth to $104.5M but persistent losses with a net margin of -57.48%. Cash flow remains negative at -$86.41M for 2025, though operating losses have narrowed from 2022 peaks.
Outlook is cautious; while technicals suggest near-term support at $8, fundamental challenges include deep losses and negative cash flow. Analyst sentiment is mixed with 60% hold ratings. Key risks are profitability timeline and competitive pressure, but rebranding and legal victories may support long-term turnaround if execution improves.
No Aura AI signal available yet.
Trailing returns across standard periods
Latest headlines on both assets
Firy Inc. operates a mobile gaming platform in the United States, Israel, China, Malta, Hong Kong, Cyprus, and other international markets. The company operates through two segments: Skillz and RZR. Its Skillz platform enables game developers to monetize their content by integrating real-money tournaments, virtual prizes, and social competition features directly into multiplayer games.
Read more on FIRY →22nd Century Group is a plant biotechnology company that uses genetic engineering and gene editing to control the levels of nicotine in tobacco plants. Its flagship product line, VLN®, is the first and only combustible cigarette authorized by the FDA as a Modified Risk Tobacco Product (MRTP), containing 95% less nicotine than traditional cigarettes to help adult smokers smoke less.
Read more on XXII →